SCHEMBL4896499

SCHEMBL4896499

C=CCOC(=O)c1cnn(-c2nccs2)c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SNCA P37840 1/20 0.40
KMT2A Q03164 4/20 0.39
ALDH1A1 P00352 4/20 0.39
PPARG P37231 1/20 0.39
MAPK10 P53779 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
MEN1 O00255 3/20 0.38
CYP3A4 P08684 1/20 0.36
SCN9A Q15858 1/20 0.35
MAPT P10636 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
EGLN1 Q9GZT9 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
SLC6A7 Q99884 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19975395 0.85 SCN9A (0.45) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL3777154 0.77 EGLN1 (0.51) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL18320461 0.76 ALDH1A1 (0.39) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL4890364 0.75 MAPT (0.42) KMT2AALDH1A1PPARGMEN1CYP3A4
SCHEMBL4897248 0.72 KDM4E (0.46) KMT2AALDH1A1MEN1CYP3A4MAPT
SCHEMBL2529820 0.68 FFAR4 (0.39) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL31517219 0.68 ALDH1A1 (0.39) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL31517602 0.67 ALDH1A1 (0.34) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL19975267 0.66 PDE10A (0.34) KMT2AALDH1A1PPARGMAPK10NPSR1
SCHEMBL23627027 0.66 SNCA (0.39) SNCAKMT2AALDH1A1MEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7358267-B2 Bis-aryl thiazole derivatives AMGEN INC. (US) 2008-04-15 US disclosed
US-20050215608-A1 Bis-aryl thiazole derivatives AMGEN INC. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215608-A1 Bis-aryl thiazole derivatives FABP4, PC, TXNRD2 SNCA 3505/4885KMT2A 4093/4885ALDH1A1 842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.